dimethyl fumarate
biogen
[' ris ']
#ectrims2022 : darin okuda, ut southwestern, shared first trial showing that treating people who have ris (#ms-like mri with no symptoms) with tecfidera over 96 weeks reduced risk of having a first neurological symptom: 
We will cure multiple sclerosis while empowering people affected by MS to live their best lives.